Constant small-cell changes and variable LEF1 expression in DUSP22-rearranged primary cutaneous anaplastic large-cell lymphoma: Analysis of the repeated biopsies of three patients

Pathol Int. 2023 Sep;73(9):456-462. doi: 10.1111/pin.13360. Epub 2023 Aug 2.

Abstract

DUSP22-rearranged primary cutaneous anaplastic large-cell lymphoma (pcALCL) has a biphasic histological pattern defined by large dermal atypical lymphocytes and epidermotropic small lymphocytes resembling pagetoid reticulosis, but the positivity rate of the biphasic pattern in DUSP22-rearranged pcALCL is unknown. Immunohistochemically, LEF1 expression in >75% of tumor cells is associated with DUSP22-rearrangement (DUSP22-R) in systemic ALCL. However, whether this association applies to pcALCL remains unclear. To analyze these pathological clues for screening DUSP22-R, we reviewed 11 skin biopsies from three patients with DUSP22-rearranged pcALCL. All specimens showed a biphasic pattern, of which three showed nonpagetoid infiltration of the epidermis. In all lesions, small-cell changes of tumor cells were observed not only within the epidermis but also under the epidermis. LEF1 positivity rates varied by lesion (range: 30%-90%, mean: 59.6%) with only three patients expressing LEF1 in more than 75% of tumor cells. In conclusion, the biphasic pattern was a constant finding in DUSP22-rearranged pcALCL, but it was not always pagetoid reticulosis-like. The recognition of small-cell change outside the epidermis may be helpful in diagnosing DUSP22-rearranged pcALCL. However, LEF1 expression was variable and its diagnostic usefulness may be limited.

Keywords: DUSP22-rearranged primary cutaneous anaplastic large cell lymphoma; LEF1; biphasic pattern; small-cell change.

Publication types

  • Review
  • Case Reports

MeSH terms

  • Biopsy
  • Dual-Specificity Phosphatases / genetics
  • Humans
  • Lymphoid Enhancer-Binding Factor 1 / genetics
  • Lymphoma, Large-Cell, Anaplastic* / pathology
  • Mitogen-Activated Protein Kinase Phosphatases / genetics
  • Pagetoid Reticulosis*
  • Skin Neoplasms* / pathology

Substances

  • LEF1 protein, human
  • Lymphoid Enhancer-Binding Factor 1
  • DUSP22 protein, human
  • Dual-Specificity Phosphatases
  • Mitogen-Activated Protein Kinase Phosphatases